IRIS
GARUTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.044
Totale 6.044
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.044
Totale 6.044
Salva come PNG Salva come JPEG
Città #
Genova 4.779
Rapallo 733
Genoa 520
Bordighera 12
Totale 6.044
Salva come PNG Salva come JPEG
Nome #
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 171
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 164
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 158
APO866 activity in hematologic malignancies: a preclinical in vitro study. 143
Ras-induced resistance to lapatinib is overcome by MEK inhibition 140
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 139
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 137
Uncovering the genomic heterogeneity of multifocal breast cancer 137
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 136
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 132
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 129
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 128
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 126
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 126
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 126
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 125
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 125
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 124
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 120
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 120
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 119
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 119
Germline mutations in the von Hippel-Lindau gene in Italian patients. 118
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 116
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 115
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 114
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 114
Mutant presenilin 1 increases the expression and activity of BACE1. 113
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 113
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 112
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 109
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 108
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 108
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 106
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 106
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 106
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 104
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 102
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 101
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 100
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 98
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 98
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 93
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 90
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 88
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 87
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 85
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 83
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 80
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 78
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 67
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 56
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 54
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 53
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 38
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 27
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 26
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 16
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 8
Totale 6.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.433
article - articoli 15.868
book - libri 0
conference - conferenze 367
curatela - curatele 0
other - altro 198
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019351 0 0 0 0 0 0 0 0 0 0 186 165
2019/20201.687 84 44 62 120 170 201 245 119 142 259 182 59
2020/2021523 30 81 30 42 32 30 28 54 45 60 55 36
2021/2022800 29 59 66 110 28 51 52 172 34 66 46 87
2022/2023900 94 98 10 100 147 121 10 65 134 1 113 7
2023/2024375 21 53 4 70 34 98 19 39 19 18 0 0
Totale 6.134